Can Statin Preventative Treatment Inform Geroscience-guided Therapeutics?

Overview

Journal Aging Cell

Specialties Cell Biology
Geriatrics

Date 2023 Oct 13

PMID 37830430

Authors

Giovanni Guaraldi

Kristine M Erlandson

Jovana Milic

Alan L Landay

Monty A Montano

Affiliations

Soon will be listed here.

Abstract

Potential senotherapeutic effect of statins may lead to prevention and reduction of frailty.

Citing Articles

The Quest for Eternal Youth: Hallmarks of Aging and Rejuvenating Therapeutic Strategies.

Nunkoo V, Cristian A, Jurcau A, Diaconu R, Jurcau M Biomedicines. 2024; 12(11).

PMID: 39595108 PMC: 11591597. DOI: 10.3390/biomedicines12112540.

Pitavastatin Is Well-Tolerated With no Detrimental Effects on Physical Function.

Erlandson K, Umbleja T, Ribaudo H, Schrack J, Overton E, Fichtenbaum C Clin Infect Dis. 2024; 80(2):425-433.

PMID: 39159048 PMC: 11848279. DOI: 10.1093/cid/ciae422.

Can statin preventative treatment inform geroscience-guided therapeutics?.

Guaraldi G, Erlandson K, Milic J, Landay A, Montano M Aging Cell. 2023; 22(12):e13998.

PMID: 37830430 PMC: 10726887. DOI: 10.1111/acel.13998.

References

Cardenas J, Oliveira V, Borsari A, Marinello P, Longenecker C, Deminice R . Statin protects men but not women with HIV against loss of muscle mass, strength, and physical function: a pilot study. Sci Rep. 2023; 13(1):4693. PMC: 10033712. DOI: 10.1038/s41598-023-31643-3. View

Toribio M, Fitch K, Stone L, Zanni M, Lo J, de Filippi C . Assessing statin effects on cardiovascular pathways in HIV using a novel proteomics approach: Analysis of data from INTREPID, a randomized controlled trial. EBioMedicine. 2018; 35:58-66. PMC: 6156703. DOI: 10.1016/j.ebiom.2018.08.039. View

Cesari M, Penninx B, Pahor M, Lauretani F, Corsi A, Williams G . Inflammatory markers and physical performance in older persons: the InCHIANTI study. J Gerontol A Biol Sci Med Sci. 2004; 59(3):242-8. DOI: 10.1093/gerona/59.3.m242. View

Ridker P, Danielson E, Fonseca F, Genest J, Gotto Jr A, Kastelein J . Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008; 359(21):2195-207. DOI: 10.1056/NEJMoa0807646. View

Mansi I, Sumithran P, Kinaan M . Risk of diabetes with statins. BMJ. 2023; 381:e071727. DOI: 10.1136/bmj-2022-071727. View

Coppe J, Patil C, Rodier F, Sun Y, Munoz D, Goldstein J . Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol. 2008; 6(12):2853-68. PMC: 2592359. DOI: 10.1371/journal.pbio.0060301. View

Guaraldi G, Erlandson K, Milic J, Landay A, Montano M . Can statin preventative treatment inform geroscience-guided therapeutics?. Aging Cell. 2023; 22(12):e13998. PMC: 10726887. DOI: 10.1111/acel.13998. View

Kelly S, Wu K, Tassiopoulos K, Erlandson K, Koletar S, Palella F . Frailty Is an Independent Risk Factor for Mortality, Cardiovascular Disease, Bone Disease, and Diabetes Among Aging Adults With Human Immunodeficiency Virus. Clin Infect Dis. 2018; 69(8):1370-1376. PMC: 6938206. DOI: 10.1093/cid/ciy1101. View

Nose D, Shiga Y, Takahashi R, Yamamoto Y, Suematsu Y, Kuwano T . Association Between Telomere G-Tail Length and Coronary Artery Disease or Statin Treatment in Patients With Cardiovascular Risks　- A Cross-Sectional Study. Circ Rep. 2023; 5(8):338-347. PMC: 10411992. DOI: 10.1253/circrep.CR-23-0038. View

10.

Abbasi F, Lamendola C, Harris C, Harris V, Tsai M, Tripathi P . Statins Are Associated With Increased Insulin Resistance and Secretion. Arterioscler Thromb Vasc Biol. 2021; 41(11):2786-2797. PMC: 8551023. DOI: 10.1161/ATVBAHA.121.316159. View

11.

Matsubayashi S, Ito S, Araya J, Kuwano K . Drugs against metabolic diseases as potential senotherapeutics for aging-related respiratory diseases. Front Endocrinol (Lausanne). 2023; 14:1079626. PMC: 10106576. DOI: 10.3389/fendo.2023.1079626. View

12.

Forman D, Maurer M, Boyd C, Brindis R, Salive M, Horne F . Multimorbidity in Older Adults With Cardiovascular Disease. J Am Coll Cardiol. 2018; 71(19):2149-2161. PMC: 6028235. DOI: 10.1016/j.jacc.2018.03.022. View

13.

Guaraldi G, De Francesco D, Milic J, Franconi I, Mussini C, Falutz J . The Interplay Between Age and Frailty in People Living With HIV: Results From an 11-Year Follow-up Observational Study. Open Forum Infect Dis. 2019; 6(5):ofz199. PMC: 6524826. DOI: 10.1093/ofid/ofz199. View

14.

Desquilbet L, Jacobson L, Fried L, Phair J, Jamieson B, Holloway M . HIV-1 infection is associated with an earlier occurrence of a phenotype related to frailty. J Gerontol A Biol Sci Med Sci. 2007; 62(11):1279-86. DOI: 10.1093/gerona/62.11.1279. View

15.

Grinspoon S, Fitch K, Zanni M, Fichtenbaum C, Umbleja T, Aberg J . Pitavastatin to Prevent Cardiovascular Disease in HIV Infection. N Engl J Med. 2023; 389(8):687-699. PMC: 10564556. DOI: 10.1056/NEJMoa2304146. View

16.

Lopez-Otin C, Blasco M, Partridge L, Serrano M, Kroemer G . The hallmarks of aging. Cell. 2013; 153(6):1194-217. PMC: 3836174. DOI: 10.1016/j.cell.2013.05.039. View

17.

Kuniholm M, Vasquez E, Appleton A, Kingsley L, Palella F, Budoff M . Cardiovascular risk score associations with frailty in men and women with or at risk for HIV. AIDS. 2021; 36(2):237-347. PMC: 8711611. DOI: 10.1097/QAD.0000000000003107. View

18.

Ferrucci L, Fabbri E . Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty. Nat Rev Cardiol. 2018; 15(9):505-522. PMC: 6146930. DOI: 10.1038/s41569-018-0064-2. View

19.

Ising C, Venegas C, Zhang S, Scheiblich H, Schmidt S, Vieira-Saecker A . NLRP3 inflammasome activation drives tau pathology. Nature. 2019; 575(7784):669-673. PMC: 7324015. DOI: 10.1038/s41586-019-1769-z. View

20.

Funderburg N, Jiang Y, Debanne S, Storer N, Labbato D, Clagett B . Rosuvastatin treatment reduces markers of monocyte activation in HIV-infected subjects on antiretroviral therapy. Clin Infect Dis. 2013; 58(4):588-95. PMC: 3905756. DOI: 10.1093/cid/cit748. View